INFECTIOLOGIE PEDIATRIQUE
0781.355.190 · rovalta.com · 27/09/2026
INFECTIOLOGIE PEDIATRIQUE
Company — Normal situation.
Strike-off: 20 mai 2026
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBOINFECTIOLOGIE PEDIATRIQUE is a Private limited company incorporated in 2022.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0781.355.190
- Incorporation
- 31/01/2022
- Legal form
- Private limited company
- Contributed capital
- 5 000,00 €
- Latest accounts
- 30/09/2025
Financials
Source · NBB, 3 filingsTrend over 3 financial years
| 2025 | 2024 | 2023 | |||
|---|---|---|---|---|---|
| Income statement | |||||
| Gross margin | 85,8 k € | -9.1% | 94,4 k € | -35.9% | 147,2 k € |
| EBITDA | 61,2 k € | -33.6% | 92,2 k € | -37.2% | 146,8 k € |
| Operating result | 61,2 k € | -15.3% | 72,3 k € | -45.6% | 132,8 k € |
| Net result | 31,1 k € | -54.4% | 68,1 k € | -25.8% | 91,8 k € |
| Balance sheet | |||||
| Equity | 196 k € | +18.8% | 164,9 k € | +70.3% | 96,8 k € |
| Total assets | 215,2 k € | -4.7% | 225,7 k € | +8.6% | 207,9 k € |
| Cash | 178,1 k € | +80.2% | 98,8 k € | -12.1% | 112,4 k € |
| Debts | 19,2 k € | -68.4% | 60,8 k € | -45.2% | 111 k € |
Board of directors
Source · NBB, accounts to 30/09/20251 active
Active mandates
| Director | Function | Mandate |
|---|---|---|
Anne TILMANNE | Mandate |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 31/01/2022 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 |
| Length of the financial year | 12 months | 12 months | 21 months |
| Filing date | 26/03/2026 | 29/04/2025 | 03/05/2024 |
| General meeting | 23/03/2026 | 27/04/2025 | 15/01/2024 |
| Currency of the financial year | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 3 filingsValuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active
Active mandates
| Director | Function | Mandate |
|---|---|---|
Anne TILMANNE | Mandate |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202531,1 k €↓
- 2024Annual accounts 202468,1 k €↓
- 2023Annual accounts 202391,8 k €
- 31/01/2022IncorporationPrivate limited company
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue aux Racines 16, 1440 Braine-le-Château | CBE until 20/05/2026 | CBE |
| Rue aux Racines 16, 1440 Braine-le-Château | accounts 2023 → 2025 | Accounts 2025 · 2026-00062627 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| INFECTIOLOGIE PEDIATRIQUE | CBE until 20/05/2026 | CBE |
| INFECTIOLOGIE PEDIATRIQUE | accounts 2023 → 2025 | Accounts 2025 · 2026-00062627 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.